LABORATORIOS LEO PHARMA, S.A. secures contract for Pharmaceutical products - Framework Agreement for the supply of medicines without competition for the hospitals of the Cantabrian Health Service (Active ingredients Brodalumab, Delgocitinib, Tralokinumab, Spesolimab)

Spain, Oct. 16 -- Spain based LABORATORIOS LEO PHARMA, S.A. has secured contract from Servicio Cantabro de Salud for Pharmaceutical products - Framework Agreement for the supply of medicines without competition for the hospitals of the Cantabrian Health Service (Active ingredients Brodalumab, Delgocitinib, Tralokinumab, Spesolimab). The value of the contract is worth 1243376 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....